Global Innovative Platforms (GIPL) Cash from Operations (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Cash from Operations came in at -$133565.0 in Q2 2026, up 27.52% year-over-year from -$104742.2 in Q2 2025, and down 118.65% quarter-over-quarter from $716175.0 in Q1 2026.
Analysis
Global Innovative Platforms (GIPL) Cash from Operations (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Cash from Operations across 7 years of filings, most recently posting -$133565.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 27.52% year-over-year to -$133565.0; the TTM figure through Jun 2026 stood at -$710926.0 (up 15.76% YoY), while the FY2025 annual figure was -$936443.0, down 149.26% from the prior year.
- Cash from Operations came in at -$133565.0 for Q2 2026 at Global Innovative Platforms, down from $716175.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of $716175.0 in Q1 2026 to a low of -$852972.0 in Q4 2025.
- Average Cash from Operations over 5 years is -$106887.9, with a median of -$61589.0 recorded in 2023.
- Year-over-year, Cash from Operations soared 66448.98% in 2022 and sank 41780.23% in 2025.
- Over 5 years, Cash from Operations stood at -$83207.0 in 2022, then jumped by 70.39% to -$24636.0 in 2023, then plunged by 1985.36% to -$513750.0 in 2024, then slumped by 66.03% to -$852972.0 in 2025, then surged by 84.34% to -$133565.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$133565.0 in Q2 2026, $716175.0 in Q1 2026, and -$852972.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 347.16 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 655.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 277.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 24.09 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -133,565.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -133,565.00 |
| Mar 31, 2026 | 716,175.00 |
| Dec 31, 2025 | -852,972.00 |
| Sep 30, 2025 | -440,564.00 |
| Jun 30, 2025 | -184,273.00 |
| Mar 31, 2025 | 202,144.00 |
| Dec 31, 2024 | -513,750.00 |
| Sep 30, 2024 | -348,028.00 |
| Jun 30, 2024 | -440.00 |
| Mar 31, 2024 | -2,589.00 |
| Dec 31, 2023 | -24,636.00 |
| Sep 30, 2023 | -129,866.00 |
| Jun 30, 2023 | -13,653.00 |
| Mar 31, 2023 | -61,589.00 |
| Dec 31, 2022 | -83,207.00 |
| Sep 30, 2022 | 65,218.00 |
| Jun 30, 2022 | -11,500.00 |
| Sep 30, 2021 | 98.00 |
| Jun 30, 2021 | 51,168.00 |
| Mar 31, 2021 | -39,951.00 |